Hospital

Pharmacy managers must be clear on, and effectively communicate state law and company policy.

A new study investigated the molecular impact of the cancer-killing PARP-1 inhibitor (PARPi) binding to PARP-1 and found that the drug can be structurally modified to increase its power to kill tumor cells.

Public policies to increase compliance with community mitigation strategies may be effective in decreasing community mobility.

Remdesivir is not yet licensed or approved anywhere internationally and has not been demonstrated to be safe or effective for the treatment of COVID-19.

COA released a statement explaining that it fundamentally opposes home infusion of chemotherapy, cancer immunotherapy, and cancer treatment supportive drugs due to concerns regarding the safety of patients in such an environment.

This medication inhaler is indicated for the treatment or prevention of bronchospasm in patients ages 4 years and older who have reversible obstructive airway disease.

Coronaviruses are known to utilize the ACE2 to help facilitate entry into the host target cell.

ASHP’s 2020 Residency Match concluded with 5269 individuals matching with 2551 pharmacy residency programs across the country.

Understanding patients' perspectives help engender their trust and loyalty, and affect positively their treatment outcomes and the pharmacy business.

Shivam Patel, PharmD, discusses one way pharmacist roles are changing during the COVID-19 pandemic.

Pharmacists on the frontlines of the pandemic need to be aware of the latest science and recommendations in order to accurately answer questions.

Today we’re celebrating all of the pharmacists and technicians at the Ann Arbor Veteran’s Affairs (VA) Hospital.

The American Society of Health-System Pharmacists has launched a new, free service to connect health care facilities with pharmacy personnel who can help alleviate potential staffing shortages.

Novartis and Rising Pharmaceuticals are donating doses of hydroxychloroquine to be utilized by researchers investigating safety and efficacy against COVID-19.

New advances in medical therapy have made it possible for rosacea patients to achieve clear skin.

The prevalence of HIV in jails and prisons is approximately 4 times higher than that of the general United States population.

According to the researchers, the case fatality rate for patients with COVID-19 and cardiovascular disease is 10.5%.

Small cell lung cancer is highly aggressive and fast-growing, typically recurring and progressing rapidly despite the initial response to chemotherapy.

During the COVID-19 pandemic, pharmacists are concerned not only about shortages in drugs that could treat the virus, but also medications for managing other conditions.

Curtis E. Haas, PharmD, FCCP, editor-in-chief of Pharmacy Times: Directions in Health-System Pharmacy, and chief pharmacy officer for the University of Rochester’s health care system, discusses preparation for potential patient surge due to COVID-19.

Recent estimates indicate that less than 10% of patients who are at risk for acquiring HIV are prescribed PrEP.

Ed Cohen, PharmD, FAPhA, executive vice president of pharmacy advocacy for the publication, was recognized with the prestigious Individual Advocate of the Year award.

These professional organizations are aware that some medications are being prophylactically prescribed as potential treatments for COVID-19.

The EUA designation allows the test to be used to detect SARS-CoV-2, the virus that causes COVID-19, for the duration of the continuing pandemic.

While remdesivir is not FDA-approved to treat the novel coronavirus, the orphan drug status would provide 7 years of exclusive marketing in the United States and tax credits on research and development costs once the drug was approved.

Gunda Siska, RPh, PharmD, discusses what she is doing as a hospital pharmacist to stay healthy.

The new guidelines recommend dosing vancomycin to achieve an area under the curve to minimum inhibitor concentration (AUC/MIC) ratio of ≥ 400.

Not enough people are taking seriously frequent recommendations to practice social distancing, he said.

The COVID-19 High Performance Computing Consortium is a partnership of federal government, tech industry, and academic leaders whose goal is to stop the virus.

Only 15% of those at risk are currently using PrEP.